Detailed information for compound 1552758

Basic information

Technical information
  • TDR Targets ID: 1552758
  • Name: 2-[(5-methyl-7-oxo-1H-[1,2,4]triazolo[4,5-a]p yrimidin-3-yl)sulfanyl]acetamide
  • MW: 239.254 | Formula: C8H9N5O2S
  • H donors: 2 H acceptors: 4 LogP: -0.92 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: NC(=O)CSc1nnc2n1c(C)cc(=O)[nH]2
  • InChi: 1S/C8H9N5O2S/c1-4-2-6(15)10-7-11-12-8(13(4)7)16-3-5(9)14/h2H,3H2,1H3,(H2,9,14)(H,10,11,15)
  • InChiKey: XSNKQSSFZAGHFL-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-[(5-methyl-7-oxo-1H-[1,2,4]triazolo[4,5-a]pyrimidin-3-yl)thio]acetamide
  • 2-[(7-keto-5-methyl-1H-[1,2,4]triazolo[4,5-a]pyrimidin-3-yl)thio]acetamide
  • 2-[(5-methyl-7-oxo-1H-[1,2,4]triazolo[4,5-a]pyrimidin-3-yl)sulfanyl]ethanamide
  • ZINC04249859
  • G856-6662
  • NCGC00136348-01

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni subfamily S9B unassigned peptidase (S09 family) 0.1723 1 1
Leishmania major oligopeptidase B-like protein,serine peptidase, clan SC, family S9A-like protein 0.0702 0.0209 0.0243
Echinococcus multilocularis prolyl endopeptidase 0.1577 0.8601 0.8601
Echinococcus granulosus prolyl endopeptidase 0.1577 0.8601 0.8601
Loa Loa (eye worm) prolyl oligopeptidase 0.1723 1 1
Mycobacterium ulcerans protease II (oligopeptidase B), PtrB 0.0702 0.0209 0.5
Trypanosoma brucei serine peptidase, clan SC, family S9A-like protein 0.0702 0.0209 0.0243
Schistosoma mansoni prolyl oligopeptidase (S09 family) 0.1577 0.8601 0.8601
Mycobacterium tuberculosis Probable protease II PtrBa [first part] (oligopeptidase B) 0.1301 0.5946 1
Trypanosoma brucei prolyl endopeptidase 0.1577 0.8601 1
Toxoplasma gondii prolyl endopeptidase 0.1577 0.8601 1
Trypanosoma cruzi oligopeptidase b 0.0702 0.0209 0.0243
Brugia malayi prolyl oligopeptidase family protein 0.1577 0.8601 0.8601
Leishmania major prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative 0.1577 0.8601 1
Trypanosoma cruzi oligopeptidase b 0.0702 0.0209 0.0243
Trypanosoma brucei oligopeptidase b 0.0702 0.0209 0.0243
Echinococcus multilocularis dipeptidyl aminopeptidaseprotein 0.1723 1 1
Trypanosoma brucei prolyl oligopeptidase, putative 0.0702 0.0209 0.0243
Schistosoma mansoni prolyl oligopeptidase (S09 family) 0.1577 0.8601 0.8601
Trypanosoma cruzi oligopeptidase B-like protein, putative 0.0702 0.0209 0.0243
Mycobacterium leprae PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) 0.0702 0.0209 0.5
Echinococcus granulosus dipeptidyl aminopeptidaseprotein 0.1723 1 1
Trypanosoma cruzi serine peptidase, clan SC, family S9A-like protein, putative 0.0702 0.0209 0.0243
Leishmania major oligopeptidase b 0.0702 0.0209 0.0243
Trypanosoma cruzi prolyl endopeptidase 0.1577 0.8601 1
Onchocerca volvulus Dipeptidyl peptidase family member 1 homolog 0.1723 1 1

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 2.5119 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.